Neoadjuvant Chemotherapy Improves the Results of Cystectomy for Muscle-invasive Bladder Cancer: Are there any Consequences for the Radiation Oncologist?;Die Neoadjuvante Chemotherapie vor Radikaler Zystektomie Verbessert die Prognose beim Muskelinvasiven Blasenkarzinom: Konsequenzen für den Radiotherapeuten?

Strahlentherapie und Onkologie

Volumn 180, Issue 4, 2004, Pages 246-247

  Weiss, Christian ^a   Rödel, Claus ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; METHOTREXATE; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; BLADDER CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CYSTECTOMY; HUMAN; MAJOR CLINICAL STUDY; NOTE; PROGNOSIS; TRANSURETHRAL RESECTION;

EID: 1842765532     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (7)

1. Advanced Bladder Cancer Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer. A systematic review and meta-analysis. Lancet 2003;361:1927-1934.
2. Grossman HB, Natale RB, Tangen CM, et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 2003;349:859-66.
3. Hall R, on behalf of the Intl Collaboration of Trialist of the MRC Advanced Bladder Cancer Group MCTU, London, UK. Updated results of a randomised controlled trial of neoadjuvant cisplatin, methotrexate and vinblastin chemotherapy for muscle-invasive bladder cancer. Proc Am Soc Clin Oncol 2002;21:178 (abstract 710).
4. Neoadjuvant cisplatin, methotrexate, and vinblastin chemotherapy for muscle-invasive bladder cancer. International collaboration of trialists. Lancet 1999;354:533-540. (Erratum in: Lancet 1999;354:1650).
5. Neoadjuvant cisplatin, methotrexate, and vinblastin chemotherapy for muscle-invasive bladder cancer. International collaboration of trialists. Lancet 1999;354:533-540. (Erratum in: Lancet 1999;354:1650).
6. Rödel C, Grabenbauer GG, Kühn R, et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: Long-term results. J Clin Oncol 2002;20:3061-71.
7. Shipley WU, Winter KA, Kaufman DS, et al. Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03. J Clin Oncol 1998;16:3576-83.